Bibliography
- SHAPIRO AJM, LAKEY JTR, RYAN EA et al.: Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl. I Med (2000) 343:230–238.
- LIM F, SUN AM: Microencapsulated islets as bioartificial endocrine pancreas. Science(1980) 210:908–910.
- LANZA RP, BEYER AM, STARUK JE, CHICK WL: Biohybrid artificial pancreas: long-term function of discordant isletxenografts in streptozotocin-diabetic rats.Transplantation (1993) 56:1067–1072.
- LUM ZP, TAI IP, KRESTOW M et al: Prolonged reversal of diabetic state in NOD mice by xenografts of microencapsulated rat islets. Diabetes (1991) 40:1511–1516.
- LANZA RP, BORLAND RM, STARUK JE et al.: Transplantation of encapsulated canine islets into spontaneously diabetic BB/ Wor rats without immunosuppression.Endocrinology (1992) 131:637–642.
- SUN Y, MAX, ZHOU DB et al.: Normalization of diabetes in spontaneouslydiabetic cynomologous monkeys by xenografts of microencapsulated porcine islets without immunosuppression. j Clin. Invest. (1996) 98:1417–1422.
- COLTON CK: Implantable biohybrid artificial organs. Cell Trans. (1995) 4:415–422.
- CALAFIORE R: Actual perspectives in biohybrid artificial pancreas for the therapy of type 1, insulin-dependent diabetes mellitus. Diabetes Metab. Rev (1998) 14(4):315–324.
- SOON-SHIONG P, HEINTZ R, MERIDETH N et al.: Insulin-independence in a Type 1 diabetic patient after encapsulated islet transplantation.Lancet (1994) 343:950–951.
- CALAFIORE R, BASTA G: Alginate/poly-L-ornithine microcapsules for pancreatic islet cell immunoprotection. In: Cell Encapsulation Technology and Therapeutics. Kuhtreiber WM, Lanza RP (Eds), Birkhauser, Ann Arbor, USA (1999):138–150.
- CALAFIORE R: Bioartificial Pancreas. In: Polymeric Biomaterials (2nd edition). Dumitriu S (Ed.), Marcel Dekker, Inc., New York (2001):983–1005.
- PATIENCE C, TAKEUCHI R, WEISS RA et al.: Infection of human cells by anendogenous retrovirus of pigs. Nat. Med.(1997) 3:282–287.
- KUMAR G, TUCH BE, DENG YM et al.:Limiting potential infectious risks of transplanting insulin-producing cells into humans. Pathology (2002) 34:178–184.
- DUVIVIER-KALI VF, OMER A, PARENT RI et al.: Complete protection of islets against allorejection by a simple barium-alginate membrane. Diabetes (2001) 50:1698–1705.
- ORIVE G, HERNANDEZ RM, GASCON AR et al.: Encapsulated cell technology: from research to market. Trends Biotechnol (2002) 20:382–387.
- CALAFIORE R, LUCA G, CALVITTI M et al.: Cellular support systems for alginate microcapsules containing islets as acomposite bioartificial pancreas. Ann. NY Acad. Sci (2001) 944:240–251.
- STRAND BL, GASEROD 0, KULSENG B et al.: Alginate-polylysine-alginate microcapsules: effect of size reduction on capsule properties.Microencaps. (2002) 19:615–630.
- CALAFIORE R, BASTA G, LUCA G et al: Alginate/polyaminoacidic coherent microcapsules for pancreatic islet graft immunoisolation in diabetic recipients.Ann. NY Acad. Sci. (1997) 831:313–322.